nodes	percent_of_prediction	percent_of_DWPC	metapath
Halofantrine—CYP2C8—Mometasone—systemic scleroderma	0.284	0.412	CbGbCtD
Halofantrine—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.117	0.171	CbGbCtD
Halofantrine—CYP2C8—Mycophenolate mofetil—systemic scleroderma	0.113	0.164	CbGbCtD
Halofantrine—CYP2D6—Captopril—systemic scleroderma	0.0915	0.133	CbGbCtD
Halofantrine—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0458	0.0666	CbGbCtD
Halofantrine—CYP3A4—Prednisone—systemic scleroderma	0.0366	0.0532	CbGbCtD
Halofantrine—Back pain—Leflunomide—systemic scleroderma	0.00108	0.00345	CcSEcCtD
Halofantrine—Malaise—Azathioprine—systemic scleroderma	0.00106	0.00341	CcSEcCtD
Halofantrine—Anorexia—Captopril—systemic scleroderma	0.00105	0.00337	CcSEcCtD
Halofantrine—Depressed level of consciousness—Methotrexate—systemic scleroderma	0.00105	0.00336	CcSEcCtD
Halofantrine—Stomatitis—Mycophenolate mofetil—systemic scleroderma	0.00104	0.00335	CcSEcCtD
Halofantrine—Asthenia—Pentoxifylline—systemic scleroderma	0.00104	0.00334	CcSEcCtD
Halofantrine—Ill-defined disorder—Leflunomide—systemic scleroderma	0.00103	0.00331	CcSEcCtD
Halofantrine—Pruritus—Pentoxifylline—systemic scleroderma	0.00103	0.0033	CcSEcCtD
Halofantrine—Back pain—Mycophenolic acid—systemic scleroderma	0.00103	0.00329	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mometasone—systemic scleroderma	0.00103	0.00329	CcSEcCtD
Halofantrine—Tinnitus—Lisinopril—systemic scleroderma	0.00102	0.00328	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.001	0.00322	CcSEcCtD
Halofantrine—Malaise—Leflunomide—systemic scleroderma	0.001	0.00322	CcSEcCtD
Halofantrine—Myalgia—Azathioprine—systemic scleroderma	0.001	0.00321	CcSEcCtD
Halofantrine—Arthralgia—Azathioprine—systemic scleroderma	0.001	0.00321	CcSEcCtD
Halofantrine—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000995	0.00319	CcSEcCtD
Halofantrine—Abdominal pain—Mometasone—systemic scleroderma	0.000992	0.00318	CcSEcCtD
Halofantrine—Discomfort—Azathioprine—systemic scleroderma	0.000991	0.00318	CcSEcCtD
Halofantrine—Paraesthesia—Captopril—systemic scleroderma	0.000989	0.00317	CcSEcCtD
Halofantrine—Chills—Lisinopril—systemic scleroderma	0.000986	0.00316	CcSEcCtD
Halofantrine—Ill-defined disorder—Mycophenolic acid—systemic scleroderma	0.000985	0.00316	CcSEcCtD
Halofantrine—Palpitations—Leflunomide—systemic scleroderma	0.000983	0.00315	CcSEcCtD
Halofantrine—Arrhythmia—Lisinopril—systemic scleroderma	0.000981	0.00314	CcSEcCtD
Halofantrine—Cough—Leflunomide—systemic scleroderma	0.000971	0.00311	CcSEcCtD
Halofantrine—Dyspepsia—Captopril—systemic scleroderma	0.00097	0.00311	CcSEcCtD
Halofantrine—Pulmonary oedema—Methotrexate—systemic scleroderma	0.000966	0.0031	CcSEcCtD
Halofantrine—Dizziness—Pentoxifylline—systemic scleroderma	0.000962	0.00308	CcSEcCtD
Halofantrine—Decreased appetite—Captopril—systemic scleroderma	0.000958	0.00307	CcSEcCtD
Halofantrine—Malaise—Mycophenolic acid—systemic scleroderma	0.000957	0.00307	CcSEcCtD
Halofantrine—Fatigue—Captopril—systemic scleroderma	0.00095	0.00304	CcSEcCtD
Halofantrine—Arthralgia—Leflunomide—systemic scleroderma	0.000947	0.00304	CcSEcCtD
Halofantrine—Chest pain—Leflunomide—systemic scleroderma	0.000947	0.00304	CcSEcCtD
Halofantrine—Myalgia—Leflunomide—systemic scleroderma	0.000947	0.00304	CcSEcCtD
Halofantrine—Constipation—Captopril—systemic scleroderma	0.000942	0.00302	CcSEcCtD
Halofantrine—Palpitations—Mycophenolic acid—systemic scleroderma	0.000938	0.00301	CcSEcCtD
Halofantrine—Discomfort—Leflunomide—systemic scleroderma	0.000936	0.003	CcSEcCtD
Halofantrine—Visual impairment—Mycophenolate mofetil—systemic scleroderma	0.000927	0.00297	CcSEcCtD
Halofantrine—Cough—Mycophenolic acid—systemic scleroderma	0.000926	0.00297	CcSEcCtD
Halofantrine—Back pain—Lisinopril—systemic scleroderma	0.000925	0.00296	CcSEcCtD
Halofantrine—Vomiting—Pentoxifylline—systemic scleroderma	0.000924	0.00296	CcSEcCtD
Halofantrine—Convulsion—Mycophenolic acid—systemic scleroderma	0.00092	0.00295	CcSEcCtD
Halofantrine—Rash—Pentoxifylline—systemic scleroderma	0.000917	0.00294	CcSEcCtD
Halofantrine—Dermatitis—Pentoxifylline—systemic scleroderma	0.000916	0.00294	CcSEcCtD
Halofantrine—Headache—Pentoxifylline—systemic scleroderma	0.000911	0.00292	CcSEcCtD
Halofantrine—Face oedema—Prednisone—systemic scleroderma	0.00091	0.00292	CcSEcCtD
Halofantrine—Anaphylactic shock—Leflunomide—systemic scleroderma	0.000908	0.00291	CcSEcCtD
Halofantrine—Feeling abnormal—Captopril—systemic scleroderma	0.000908	0.00291	CcSEcCtD
Halofantrine—Chest pain—Mycophenolic acid—systemic scleroderma	0.000904	0.0029	CcSEcCtD
Halofantrine—Myalgia—Mycophenolic acid—systemic scleroderma	0.000904	0.0029	CcSEcCtD
Halofantrine—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000904	0.0029	CcSEcCtD
Halofantrine—Gastrointestinal pain—Captopril—systemic scleroderma	0.000901	0.00289	CcSEcCtD
Halofantrine—Asthenia—Mometasone—systemic scleroderma	0.0009	0.00288	CcSEcCtD
Halofantrine—Tinnitus—Mycophenolate mofetil—systemic scleroderma	0.000897	0.00288	CcSEcCtD
Halofantrine—Discomfort—Mycophenolic acid—systemic scleroderma	0.000893	0.00286	CcSEcCtD
Halofantrine—Pruritus—Mometasone—systemic scleroderma	0.000888	0.00284	CcSEcCtD
Halofantrine—Ill-defined disorder—Lisinopril—systemic scleroderma	0.000887	0.00284	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000876	0.00281	CcSEcCtD
Halofantrine—Confusional state—Mycophenolic acid—systemic scleroderma	0.000874	0.0028	CcSEcCtD
Halofantrine—Abdominal pain—Captopril—systemic scleroderma	0.000871	0.00279	CcSEcCtD
Halofantrine—Anorexia—Leflunomide—systemic scleroderma	0.000866	0.00277	CcSEcCtD
Halofantrine—Nausea—Pentoxifylline—systemic scleroderma	0.000864	0.00277	CcSEcCtD
Halofantrine—Chills—Mycophenolate mofetil—systemic scleroderma	0.000864	0.00277	CcSEcCtD
Halofantrine—Malaise—Lisinopril—systemic scleroderma	0.000862	0.00276	CcSEcCtD
Halofantrine—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.00086	0.00276	CcSEcCtD
Halofantrine—Diarrhoea—Mometasone—systemic scleroderma	0.000858	0.00275	CcSEcCtD
Halofantrine—Palpitations—Lisinopril—systemic scleroderma	0.000845	0.00271	CcSEcCtD
Halofantrine—Cough—Lisinopril—systemic scleroderma	0.000834	0.00267	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000827	0.00265	CcSEcCtD
Halofantrine—Anorexia—Mycophenolic acid—systemic scleroderma	0.000826	0.00265	CcSEcCtD
Halofantrine—Abdominal distension—Prednisone—systemic scleroderma	0.00082	0.00263	CcSEcCtD
Halofantrine—Paraesthesia—Leflunomide—systemic scleroderma	0.000816	0.00261	CcSEcCtD
Halofantrine—Arthralgia—Lisinopril—systemic scleroderma	0.000814	0.00261	CcSEcCtD
Halofantrine—Myalgia—Lisinopril—systemic scleroderma	0.000814	0.00261	CcSEcCtD
Halofantrine—Chest pain—Lisinopril—systemic scleroderma	0.000814	0.00261	CcSEcCtD
Halofantrine—Back pain—Mycophenolate mofetil—systemic scleroderma	0.00081	0.0026	CcSEcCtD
Halofantrine—Discomfort—Lisinopril—systemic scleroderma	0.000804	0.00258	CcSEcCtD
Halofantrine—Cerebrovascular accident—Methotrexate—systemic scleroderma	0.000804	0.00258	CcSEcCtD
Halofantrine—Dyspepsia—Leflunomide—systemic scleroderma	0.000799	0.00256	CcSEcCtD
Halofantrine—Vomiting—Mometasone—systemic scleroderma	0.000798	0.00256	CcSEcCtD
Halofantrine—Feeling abnormal—Azathioprine—systemic scleroderma	0.000792	0.00254	CcSEcCtD
Halofantrine—Rash—Mometasone—systemic scleroderma	0.000791	0.00254	CcSEcCtD
Halofantrine—Asthenia—Captopril—systemic scleroderma	0.000791	0.00253	CcSEcCtD
Halofantrine—Dermatitis—Mometasone—systemic scleroderma	0.00079	0.00253	CcSEcCtD
Halofantrine—Decreased appetite—Leflunomide—systemic scleroderma	0.000789	0.00253	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000789	0.00253	CcSEcCtD
Halofantrine—Confusional state—Lisinopril—systemic scleroderma	0.000787	0.00252	CcSEcCtD
Halofantrine—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000786	0.00252	CcSEcCtD
Halofantrine—Headache—Mometasone—systemic scleroderma	0.000786	0.00252	CcSEcCtD
Halofantrine—Fatigue—Leflunomide—systemic scleroderma	0.000783	0.00251	CcSEcCtD
Halofantrine—Anaphylactic shock—Lisinopril—systemic scleroderma	0.00078	0.0025	CcSEcCtD
Halofantrine—Pruritus—Captopril—systemic scleroderma	0.00078	0.0025	CcSEcCtD
Halofantrine—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000778	0.00249	CcSEcCtD
Halofantrine—Ill-defined disorder—Mycophenolate mofetil—systemic scleroderma	0.000777	0.00249	CcSEcCtD
Halofantrine—Constipation—Leflunomide—systemic scleroderma	0.000777	0.00249	CcSEcCtD
Halofantrine—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000763	0.00244	CcSEcCtD
Halofantrine—Abdominal pain—Azathioprine—systemic scleroderma	0.00076	0.00244	CcSEcCtD
Halofantrine—Malaise—Mycophenolate mofetil—systemic scleroderma	0.000756	0.00242	CcSEcCtD
Halofantrine—Diarrhoea—Captopril—systemic scleroderma	0.000754	0.00242	CcSEcCtD
Halofantrine—Decreased appetite—Mycophenolic acid—systemic scleroderma	0.000753	0.00241	CcSEcCtD
Halofantrine—Feeling abnormal—Leflunomide—systemic scleroderma	0.000748	0.0024	CcSEcCtD
Halofantrine—Fatigue—Mycophenolic acid—systemic scleroderma	0.000747	0.00239	CcSEcCtD
Halofantrine—Nausea—Mometasone—systemic scleroderma	0.000745	0.00239	CcSEcCtD
Halofantrine—Anorexia—Lisinopril—systemic scleroderma	0.000744	0.00238	CcSEcCtD
Halofantrine—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000743	0.00238	CcSEcCtD
Halofantrine—Constipation—Mycophenolic acid—systemic scleroderma	0.000741	0.00237	CcSEcCtD
Halofantrine—Palpitations—Mycophenolate mofetil—systemic scleroderma	0.00074	0.00237	CcSEcCtD
Halofantrine—Cough—Mycophenolate mofetil—systemic scleroderma	0.000731	0.00234	CcSEcCtD
Halofantrine—Dizziness—Captopril—systemic scleroderma	0.000729	0.00234	CcSEcCtD
Halofantrine—Convulsion—Mycophenolate mofetil—systemic scleroderma	0.000726	0.00233	CcSEcCtD
Halofantrine—Urticaria—Leflunomide—systemic scleroderma	0.000721	0.00231	CcSEcCtD
Halofantrine—Abdominal pain—Leflunomide—systemic scleroderma	0.000718	0.0023	CcSEcCtD
Halofantrine—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000714	0.00229	CcSEcCtD
Halofantrine—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000713	0.00229	CcSEcCtD
Halofantrine—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000713	0.00229	CcSEcCtD
Halofantrine—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000713	0.00229	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000711	0.00228	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000708	0.00227	CcSEcCtD
Halofantrine—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000705	0.00226	CcSEcCtD
Halofantrine—Paraesthesia—Lisinopril—systemic scleroderma	0.000701	0.00225	CcSEcCtD
Halofantrine—Vomiting—Captopril—systemic scleroderma	0.000701	0.00225	CcSEcCtD
Halofantrine—Rash—Captopril—systemic scleroderma	0.000695	0.00223	CcSEcCtD
Halofantrine—Dermatitis—Captopril—systemic scleroderma	0.000694	0.00222	CcSEcCtD
Halofantrine—Headache—Captopril—systemic scleroderma	0.00069	0.00221	CcSEcCtD
Halofantrine—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000689	0.00221	CcSEcCtD
Halofantrine—Dyspepsia—Lisinopril—systemic scleroderma	0.000687	0.0022	CcSEcCtD
Halofantrine—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000685	0.00219	CcSEcCtD
Halofantrine—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000684	0.00219	CcSEcCtD
Halofantrine—Decreased appetite—Lisinopril—systemic scleroderma	0.000678	0.00217	CcSEcCtD
Halofantrine—Fatigue—Lisinopril—systemic scleroderma	0.000673	0.00216	CcSEcCtD
Halofantrine—Constipation—Lisinopril—systemic scleroderma	0.000667	0.00214	CcSEcCtD
Halofantrine—Diarrhoea—Azathioprine—systemic scleroderma	0.000658	0.00211	CcSEcCtD
Halofantrine—Nausea—Captopril—systemic scleroderma	0.000655	0.0021	CcSEcCtD
Halofantrine—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000652	0.00209	CcSEcCtD
Halofantrine—Asthenia—Leflunomide—systemic scleroderma	0.000652	0.00209	CcSEcCtD
Halofantrine—Feeling abnormal—Lisinopril—systemic scleroderma	0.000643	0.00206	CcSEcCtD
Halofantrine—Pruritus—Leflunomide—systemic scleroderma	0.000643	0.00206	CcSEcCtD
Halofantrine—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000638	0.00204	CcSEcCtD
Halofantrine—Dizziness—Azathioprine—systemic scleroderma	0.000636	0.00204	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000623	0.002	CcSEcCtD
Halofantrine—Asthenia—Mycophenolic acid—systemic scleroderma	0.000622	0.00199	CcSEcCtD
Halofantrine—Diarrhoea—Leflunomide—systemic scleroderma	0.000621	0.00199	CcSEcCtD
Halofantrine—Urticaria—Lisinopril—systemic scleroderma	0.00062	0.00199	CcSEcCtD
Halofantrine—Abdominal pain—Lisinopril—systemic scleroderma	0.000617	0.00198	CcSEcCtD
Halofantrine—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000614	0.00197	CcSEcCtD
Halofantrine—Pruritus—Mycophenolic acid—systemic scleroderma	0.000613	0.00196	CcSEcCtD
Halofantrine—Vomiting—Azathioprine—systemic scleroderma	0.000611	0.00196	CcSEcCtD
Halofantrine—Rash—Azathioprine—systemic scleroderma	0.000606	0.00194	CcSEcCtD
Halofantrine—Dermatitis—Azathioprine—systemic scleroderma	0.000606	0.00194	CcSEcCtD
Halofantrine—Headache—Azathioprine—systemic scleroderma	0.000602	0.00193	CcSEcCtD
Halofantrine—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000602	0.00193	CcSEcCtD
Halofantrine—Dizziness—Leflunomide—systemic scleroderma	0.000601	0.00192	CcSEcCtD
Halofantrine—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000594	0.0019	CcSEcCtD
Halofantrine—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000593	0.0019	CcSEcCtD
Halofantrine—Stomatitis—Methotrexate—systemic scleroderma	0.000592	0.0019	CcSEcCtD
Halofantrine—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000585	0.00187	CcSEcCtD
Halofantrine—Arrhythmia—Prednisone—systemic scleroderma	0.000583	0.00187	CcSEcCtD
Halofantrine—Vomiting—Leflunomide—systemic scleroderma	0.000577	0.00185	CcSEcCtD
Halofantrine—Dizziness—Mycophenolic acid—systemic scleroderma	0.000573	0.00184	CcSEcCtD
Halofantrine—Rash—Leflunomide—systemic scleroderma	0.000573	0.00184	CcSEcCtD
Halofantrine—Dermatitis—Leflunomide—systemic scleroderma	0.000572	0.00183	CcSEcCtD
Halofantrine—Nausea—Azathioprine—systemic scleroderma	0.000571	0.00183	CcSEcCtD
Halofantrine—Headache—Leflunomide—systemic scleroderma	0.000569	0.00182	CcSEcCtD
Halofantrine—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000563	0.00181	CcSEcCtD
Halofantrine—Asthenia—Lisinopril—systemic scleroderma	0.00056	0.00179	CcSEcCtD
Halofantrine—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000559	0.00179	CcSEcCtD
Halofantrine—Pruritus—Lisinopril—systemic scleroderma	0.000552	0.00177	CcSEcCtD
Halofantrine—Vomiting—Mycophenolic acid—systemic scleroderma	0.000551	0.00177	CcSEcCtD
Halofantrine—Rash—Mycophenolic acid—systemic scleroderma	0.000546	0.00175	CcSEcCtD
Halofantrine—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000546	0.00175	CcSEcCtD
Halofantrine—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000543	0.00174	CcSEcCtD
Halofantrine—Headache—Mycophenolic acid—systemic scleroderma	0.000543	0.00174	CcSEcCtD
Halofantrine—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000541	0.00173	CcSEcCtD
Halofantrine—Nausea—Leflunomide—systemic scleroderma	0.000539	0.00173	CcSEcCtD
Halofantrine—Diarrhoea—Lisinopril—systemic scleroderma	0.000534	0.00171	CcSEcCtD
Halofantrine—Ill-defined disorder—Prednisone—systemic scleroderma	0.000527	0.00169	CcSEcCtD
Halofantrine—Visual impairment—Methotrexate—systemic scleroderma	0.000525	0.00168	CcSEcCtD
Halofantrine—Dizziness—Lisinopril—systemic scleroderma	0.000516	0.00165	CcSEcCtD
Halofantrine—Nausea—Mycophenolic acid—systemic scleroderma	0.000515	0.00165	CcSEcCtD
Halofantrine—Malaise—Prednisone—systemic scleroderma	0.000512	0.00164	CcSEcCtD
Halofantrine—Tinnitus—Methotrexate—systemic scleroderma	0.000508	0.00163	CcSEcCtD
Halofantrine—Vomiting—Lisinopril—systemic scleroderma	0.000496	0.00159	CcSEcCtD
Halofantrine—Rash—Lisinopril—systemic scleroderma	0.000492	0.00158	CcSEcCtD
Halofantrine—Convulsion—Prednisone—systemic scleroderma	0.000492	0.00158	CcSEcCtD
Halofantrine—Dermatitis—Lisinopril—systemic scleroderma	0.000492	0.00158	CcSEcCtD
Halofantrine—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000491	0.00157	CcSEcCtD
Halofantrine—Chills—Methotrexate—systemic scleroderma	0.000489	0.00157	CcSEcCtD
Halofantrine—Headache—Lisinopril—systemic scleroderma	0.000489	0.00157	CcSEcCtD
Halofantrine—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000484	0.00155	CcSEcCtD
Halofantrine—Myalgia—Prednisone—systemic scleroderma	0.000483	0.00155	CcSEcCtD
Halofantrine—Arthralgia—Prednisone—systemic scleroderma	0.000483	0.00155	CcSEcCtD
Halofantrine—Discomfort—Prednisone—systemic scleroderma	0.000478	0.00153	CcSEcCtD
Halofantrine—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000468	0.0015	CcSEcCtD
Halofantrine—Nausea—Lisinopril—systemic scleroderma	0.000464	0.00149	CcSEcCtD
Halofantrine—Anaphylactic shock—Prednisone—systemic scleroderma	0.000463	0.00149	CcSEcCtD
Halofantrine—Back pain—Methotrexate—systemic scleroderma	0.000459	0.00147	CcSEcCtD
Halofantrine—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000452	0.00145	CcSEcCtD
Halofantrine—Anorexia—Prednisone—systemic scleroderma	0.000442	0.00142	CcSEcCtD
Halofantrine—Ill-defined disorder—Methotrexate—systemic scleroderma	0.00044	0.00141	CcSEcCtD
Halofantrine—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000435	0.00139	CcSEcCtD
Halofantrine—Rash—Mycophenolate mofetil—systemic scleroderma	0.000431	0.00138	CcSEcCtD
Halofantrine—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000431	0.00138	CcSEcCtD
Halofantrine—Headache—Mycophenolate mofetil—systemic scleroderma	0.000428	0.00137	CcSEcCtD
Halofantrine—Malaise—Methotrexate—systemic scleroderma	0.000428	0.00137	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000422	0.00135	CcSEcCtD
Halofantrine—Paraesthesia—Prednisone—systemic scleroderma	0.000416	0.00133	CcSEcCtD
Halofantrine—Cough—Methotrexate—systemic scleroderma	0.000414	0.00133	CcSEcCtD
Halofantrine—Convulsion—Methotrexate—systemic scleroderma	0.000411	0.00132	CcSEcCtD
Halofantrine—Dyspepsia—Prednisone—systemic scleroderma	0.000408	0.00131	CcSEcCtD
Halofantrine—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000406	0.0013	CcSEcCtD
Halofantrine—Myalgia—Methotrexate—systemic scleroderma	0.000404	0.00129	CcSEcCtD
Halofantrine—Arthralgia—Methotrexate—systemic scleroderma	0.000404	0.00129	CcSEcCtD
Halofantrine—Chest pain—Methotrexate—systemic scleroderma	0.000404	0.00129	CcSEcCtD
Halofantrine—Decreased appetite—Prednisone—systemic scleroderma	0.000403	0.00129	CcSEcCtD
Halofantrine—Fatigue—Prednisone—systemic scleroderma	0.0004	0.00128	CcSEcCtD
Halofantrine—Discomfort—Methotrexate—systemic scleroderma	0.000399	0.00128	CcSEcCtD
Halofantrine—Constipation—Prednisone—systemic scleroderma	0.000396	0.00127	CcSEcCtD
Halofantrine—Confusional state—Methotrexate—systemic scleroderma	0.000391	0.00125	CcSEcCtD
Halofantrine—Anaphylactic shock—Methotrexate—systemic scleroderma	0.000387	0.00124	CcSEcCtD
Halofantrine—Feeling abnormal—Prednisone—systemic scleroderma	0.000382	0.00122	CcSEcCtD
Halofantrine—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000379	0.00121	CcSEcCtD
Halofantrine—Anorexia—Methotrexate—systemic scleroderma	0.000369	0.00118	CcSEcCtD
Halofantrine—Urticaria—Prednisone—systemic scleroderma	0.000368	0.00118	CcSEcCtD
Halofantrine—Abdominal pain—Prednisone—systemic scleroderma	0.000366	0.00117	CcSEcCtD
Halofantrine—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000353	0.00113	CcSEcCtD
Halofantrine—Paraesthesia—Methotrexate—systemic scleroderma	0.000348	0.00111	CcSEcCtD
Halofantrine—Dyspepsia—Methotrexate—systemic scleroderma	0.000341	0.00109	CcSEcCtD
Halofantrine—Decreased appetite—Methotrexate—systemic scleroderma	0.000337	0.00108	CcSEcCtD
Halofantrine—Fatigue—Methotrexate—systemic scleroderma	0.000334	0.00107	CcSEcCtD
Halofantrine—Asthenia—Prednisone—systemic scleroderma	0.000333	0.00107	CcSEcCtD
Halofantrine—Pruritus—Prednisone—systemic scleroderma	0.000328	0.00105	CcSEcCtD
Halofantrine—Feeling abnormal—Methotrexate—systemic scleroderma	0.000319	0.00102	CcSEcCtD
Halofantrine—Diarrhoea—Prednisone—systemic scleroderma	0.000317	0.00102	CcSEcCtD
Halofantrine—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000317	0.00102	CcSEcCtD
Halofantrine—Urticaria—Methotrexate—systemic scleroderma	0.000308	0.000986	CcSEcCtD
Halofantrine—Dizziness—Prednisone—systemic scleroderma	0.000306	0.000982	CcSEcCtD
Halofantrine—Abdominal pain—Methotrexate—systemic scleroderma	0.000306	0.000981	CcSEcCtD
Halofantrine—Vomiting—Prednisone—systemic scleroderma	0.000295	0.000944	CcSEcCtD
Halofantrine—Rash—Prednisone—systemic scleroderma	0.000292	0.000936	CcSEcCtD
Halofantrine—Dermatitis—Prednisone—systemic scleroderma	0.000292	0.000936	CcSEcCtD
Halofantrine—Headache—Prednisone—systemic scleroderma	0.00029	0.00093	CcSEcCtD
Halofantrine—Asthenia—Methotrexate—systemic scleroderma	0.000278	0.000891	CcSEcCtD
Halofantrine—Nausea—Prednisone—systemic scleroderma	0.000275	0.000882	CcSEcCtD
Halofantrine—Pruritus—Methotrexate—systemic scleroderma	0.000274	0.000878	CcSEcCtD
Halofantrine—Diarrhoea—Methotrexate—systemic scleroderma	0.000265	0.000849	CcSEcCtD
Halofantrine—Dizziness—Methotrexate—systemic scleroderma	0.000256	0.000821	CcSEcCtD
Halofantrine—Vomiting—Methotrexate—systemic scleroderma	0.000246	0.000789	CcSEcCtD
Halofantrine—Rash—Methotrexate—systemic scleroderma	0.000244	0.000783	CcSEcCtD
Halofantrine—Dermatitis—Methotrexate—systemic scleroderma	0.000244	0.000782	CcSEcCtD
Halofantrine—Headache—Methotrexate—systemic scleroderma	0.000243	0.000778	CcSEcCtD
Halofantrine—Nausea—Methotrexate—systemic scleroderma	0.00023	0.000737	CcSEcCtD
